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Abstract
Magnetic resonance imaging remains the only non-invasive method
to assess the quality of cartilage repair procedures, but ideally
would be complemented by other modalities, particularly blood
tests. Nganvongpanit and colleagues investigated serum levels of
hyaluronic acid (HA) and chondroitin sulfate (CS) for their
correlation with tissue quality after cartilage repair with autologous
chondrocytes versus subchondral drilling in a dog model. They
reported better tissue quality in animals treated with chondrocyte
implantation. Serum levels correlated with the histological score of
biopsy samples: CS showed a negative (r = –0.69) and HA a
positive (r = +0.46) correlation. Many questions remain to be
answered before serum markers can provide a reliable, non-
invasive tool to assess tissue quality, but these data provide an
important foundation for additional research.
In the previous issue of Arthritis Research & Therapy,
Nganvongpanit and colleagues [1], of Chiang Mai University
in Thailand, investigated the potential use of serum
biomarkers, such as hyaluronic acid (HA) and chondroitin
sulfate (CS), to evaluate healing after cartilage repair
procedures. They randomly assigned dogs to treatment with
autologous chondrocyte implantation (ACI) versus
subchondral drilling (SD) and followed the animals for
24 weeks post-operatively with multiple blood draws and a
cartilage biopsy at final follow-up.
Cartilage defects are a common diagnosis, encountered in
over 60% of knee arthroscopies [2]. While the natural history
and pathophysiology of cartilage defects remain controver-
sial, a significant number of patients present with symptoms
that warrant surgical intervention. These patients undergo
various cartilage repair procedures to repair the damaged
articular surfaces, including microfracture, osteochondral
autografting, and ACI. Progress in the field of cartilage repair
has been impeded in part by the relative lack of adequate
instruments to evaluate the quality of the reparative tissue.
While histological evaluation is desirable, researchers have
found it difficult to recruit patients for a second surgical
procedure to harvest a tissue biopsy solely for research
purposes. Imaging techniques, especially magnetic reso-
nance imaging (MRI), have made significant progress in
recent years. Certain cartilage-specific techniques such as
delayed gadolinium-enhanced MRI of cartilage (dGEMRIC)
and T1-rho and T2-mapping have promise to assess tissue
quality by indirectly measuring glycosaminoglycan content
[3,4]. However, these techniques are associated with sub-
stantial cost and potential risk to the patient from contrast
exposure; therefore, the development of alternative non-
invasive techniques is desirable. In particular, blood tests,
which could be repeated multiple times with minimal dis-
comfort to the patient, would present an ideal method to
investigate the maturation of repair tissue after cartilage
repair. Beyond the scientific benefit of comparing the relative
time courses of healing after different repair techniques, once
thresholds are established, biomarkers could provide clinical
guidance regarding the point when patients might return to
full activities.
In their article, Nganvongpanit and colleagues investigated
the use of monoclonal antibodies and enzyme-linked immuno-
sorbent assay to quantify serum levels of CS and HA,
respectively, in a dog model. They followed two groups
treated with either SD or autologous chondrocytes (ACs) for
24 weeks, with blood draws at baseline and every 6 weeks
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thereafter. Other endpoints included the gross visual evalu-
ation of the reparative tissue as well as histologic grading.
Animals treated with ACs demonstrated better visual and
histological appearance than those treated with drilling. Three
of the five AC biopsies were near normal, and the other two
showed at least 50% fill and peripheral integration of the
repair site. In the SD group, three of five samples demon-
strated complete degeneration, and the other two only
inconsistent fill and no peripheral integration with the
surrounding articular surface. Histologically, both groups
demonstrated some fibrocartilage; however, the AC group
also showed hyaline cartilage compared with fibrous tissue in
the SD group.
Interestingly, serum levels of CS and HA demonstrated
different trends at final follow-up after 24 weeks: CS had a
strong negative correlation with histological scores (r = –0.69),
while HA was positively correlated (r = +0.46). In the AC
group, CS levels trended downward over time, a finding the
authors interpret as a reflection of the normalizing proteo-
glycan turnover due to a successful repair with maturing
tissue. In the SD group, however, levels remained high,
possibly reflecting the progressive damage of the
surrounding cartilage seen in these samples. Overall, HA
levels also decreased from baseline, with relatively higher
values in samples with better histological scores, potentially a
sign of normalization of joint homeostasis.
This study provided two important findings. First, it added to
the mounting evidence of improved histological outcomes
with cell-based therapy, such as ACI [5], over marrow-
stimulation techniques, such as SD or microfracture. Second,
the authors describe two potential candidate factors to follow
tissue maturation and healing: HA and CS. Many questions
remain to be addressed, such as the correlation of marker
levels with defect size, number, and location as well as
possible differences between chondral and osteochondral
defects and patient gender, age, or weight. However, these
preliminary results are promising and provide a foundation for
future research.
In conclusion, while these findings require larger, confir-
matory studies (ideally in human patients), they hold promise
for non-invasive monitoring after cartilage repair procedures.
Reliable, reproducible, and relatively inexpensive methods to
evaluate the quality and maturation of reparative tissue will
substantially advance the field of cartilage repair. These tests
would potentially enable investigators and industry to develop
new technologies aimed at repairing articular cartilage, assist
surgeons to select the appropriate procedure for any given
patient, and post-operatively, allow an individualized
determination of when it is safe for the patient to return to
higher levels of activity.
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